BCYC
Price
$14.71
Change
-$0.29 (-1.93%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
ORMP
Price
$2.38
Change
-$0.11 (-4.42%)
Updated
Dec 20, 04:59 PM (EDT)
67 days until earnings call
Ad is loading...

BCYC vs ORMP

Header iconBCYC vs ORMP Comparison
Open Charts BCYC vs ORMPBanner chart's image
Bicycle Therapeutics
Price$14.71
Change-$0.29 (-1.93%)
Volume$4.49K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.38
Change-$0.11 (-4.42%)
Volume$2.34K
CapitalizationN/A
BCYC vs ORMP Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. ORMP commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (BCYC: $14.68 vs. ORMP: $2.38)
Brand notoriety: BCYC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 54% vs. ORMP: 66%
Market capitalization -- BCYC: $1.01B vs. ORMP: $95.94M
BCYC [@Biotechnology] is valued at $1.01B. ORMP’s [@Biotechnology] market capitalization is $95.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • ORMP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than ORMP.

Price Growth

BCYC (@Biotechnology) experienced а +6.30% price change this week, while ORMP (@Biotechnology) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 04, 2025.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($1.01B) has a higher market cap than ORMP($95.9M). ORMP YTD gains are higher at: 3.030 vs. BCYC (-18.805). ORMP has higher annual earnings (EBITDA): 9.44M vs. BCYC (-160.02M). BCYC has more cash in the bank: 891M vs. ORMP (142M). ORMP has less debt than BCYC: ORMP (429K) vs BCYC (11.1M). BCYC has higher revenues than ORMP: BCYC (36.9M) vs ORMP (0).
BCYCORMPBCYC / ORMP
Capitalization1.01B95.9M1,057%
EBITDA-160.02M9.44M-1,695%
Gain YTD-18.8053.030-621%
P/E RatioN/A21.64-
Revenue36.9M0-
Total Cash891M142M627%
Total Debt11.1M429K2,587%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCORMP
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AREAX14.200.24
+1.72%
AB Global Real Estate Investment A
WFPCX42.940.47
+1.11%
Allspring Special Mid Cap Value C
PSBMX25.460.26
+1.03%
Principal SmallCap R3
NAWGX45.310.34
+0.76%
Voya Global High Dividend Low Vol A
FBSRX34.84-1.49
-4.09%
Franklin Mutual U.S. Mid Cap Value R

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.13%
RPTX - BCYC
45%
Loosely correlated
N/A
PHIO - BCYC
41%
Loosely correlated
+1.15%
RLAY - BCYC
40%
Loosely correlated
-2.23%
EDIT - BCYC
38%
Loosely correlated
-2.24%
SRRK - BCYC
36%
Loosely correlated
+6.44%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.42%
BPMC - ORMP
44%
Loosely correlated
+1.42%
BTAI - ORMP
44%
Loosely correlated
+7.29%
INO - ORMP
44%
Loosely correlated
-0.81%
MBIO - ORMP
44%
Loosely correlated
+4.78%
VERV - ORMP
44%
Loosely correlated
+11.34%
More